Clinical Trial Update: A Study of BMS-986148 in Patients With Select Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Early-phase study of BMS-986148 in advanced solid tumors was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-986148

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-08-18